AIM vs GILD: Which Stock is Better?
Side-by-side comparison of Aim Immunotech Inc and Gilead Sciences Inc in 2026
AIM
Aim Immunotech Inc
$0.24
GILD
Gilead Sciences Inc
$134.36
Key Metrics Comparison
| Metric | AIM | GILD | Winner |
|---|---|---|---|
| Market Cap | $3.45M | $166.82B | GILD |
| P/E Ratio | N/A | 18.28 | GILD |
| EPS (TTM) | $N/A | $7.35 | GILD |
| Revenue Growth | -0.5% | 0.0% | GILD |
| Gross Margin | -45.5% | 79.4% | GILD |
Analyze AIM
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AIM or GILD a better investment?
Comparing AIM and GILD: Aim Immunotech Inc has a market cap of $3.45M while Gilead Sciences Inc has $166.82B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AIM and GILD?
AIM (Aim Immunotech Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AIM or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AIM or GILD?
GILD has higher revenue growth at 0.0% vs -0.5% for AIM.
Which company is more profitable: AIM or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 79.4% compared to -45.5% for AIM.
Which is the larger company: AIM or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $166.82B compared to $3.45M for AIM.
Should I buy AIM or GILD in 2026?
Both AIM and GILD have investment merit. AIM trades at $0.24 while GILD trades at $134.36. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AIM and GILD stock?
Key differences: Market Cap ($3.45M vs $166.82B), P/E Ratio (N/A vs 18.3x), Revenue Growth (-0.5% vs 0.0%), Gross Margin (-45.5% vs 79.4%).